{"id":"https://openalex.org/W7224331014","doi":"https://doi.org/10.3389/fphar.2026.1934274","title":"Early postmarketing reporting patterns of resmetirom in FAERS: disproportionality analyses with indication-restricted and active comparators","display_name":"Early postmarketing reporting patterns of resmetirom in FAERS: disproportionality analyses with indication-restricted and active comparators","publication_year":2026,"publication_date":"2026-10-29","ids":{"openalex":"https://openalex.org/W7224331014","doi":"https://doi.org/10.3389/fphar.2026.1934274"},"language":"en","primary_location":{"id":"doi:10.3389/fphar.2026.1934274","doi":"https://doi.org/10.3389/fphar.2026.1934274","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1934274","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1934274/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1934274/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5160079147","display_name":"Xin Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Zhao","raw_affiliation_strings":["Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160071160","display_name":"Bi Pan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Bi Pan","raw_affiliation_strings":["Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160071631","display_name":"Tianhao Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Tianhao Chen","raw_affiliation_strings":["Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100458639","display_name":"Jingyi Zhang","orcid":"https://orcid.org/0009-0008-9845-6984","observed_orcids":["https://orcid.org/0009-0008-9845-6984"]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jingyi Zhang","raw_affiliation_strings":["Department of Ultrasonography, West China Hospital, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Ultrasonography, West China Hospital, Sichuan University","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160078819","display_name":"Rongxing Zhou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I24185976","display_name":"Sichuan University","ror":"https://ror.org/011ashp19","country_code":"CN","type":"education","lineage":["https://openalex.org/I24185976"]},{"id":"https://openalex.org/I4210089761","display_name":"West China Hospital of Sichuan University","ror":"https://ror.org/007mrxy13","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210089761"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Rongxing Zhou","raw_affiliation_strings":["Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of General Surgery, Division of Biliary Tract Surgery, West China, Hospital, Sichuan University","institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5160078819"],"corresponding_institution_ids":["https://openalex.org/I24185976","https://openalex.org/I4210089761"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84992481,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11465","display_name":"Drug-Induced Hepatotoxicity and Protection","score":0.001500000013038516,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11649","display_name":"Pharmaceutical industry and healthcare","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/resmetirom","display_name":"resmetirom","score":0.9990000128746033},{"id":"https://openalex.org/keywords/thyroid-hormone-receptor-beta-agonist","display_name":"thyroid hormone receptor beta agonist","score":0.699999988079071},{"id":"https://openalex.org/keywords/non-alcoholic-steatohepatitis","display_name":"nonalcoholic steatohepatitis","score":0.9580000042915344},{"id":"https://openalex.org/keywords/hepatotoxicity","display_name":"hepatotoxicity","score":0.6039999723434448},{"id":"https://openalex.org/keywords/cholestasis","display_name":"cholestasis","score":0.8740000128746033},{"id":"https://openalex.org/keywords/adverse-event-reporting","display_name":"adverse event reporting","score":0.5490000247955322},{"id":"https://openalex.org/keywords/disproportionality-analysis","display_name":"disproportionality analysis","score":0.699999988079071},{"id":"https://openalex.org/keywords/active-comparator","display_name":"active comparator","score":0.6309999823570251},{"id":"https://openalex.org/keywords/gip-glp-1-receptor-agonist","display_name":"GIP/GLP-1 receptor agonist","score":0.7369999885559082},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.48899999260902405},{"id":"https://openalex.org/keywords/liver-directed-therapy","display_name":"liver-directed therapy","score":0.4740000069141388},{"id":"https://openalex.org/keywords/liver-cirrhosis","display_name":"liver cirrhosis","score":0.5379999876022339},{"id":"https://openalex.org/keywords/gastrointestinal-intolerance","display_name":"gastrointestinal intolerance","score":0.6050000190734863},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.37700000405311584},{"id":"https://openalex.org/keywords/gemfibrozil","display_name":"gemfibrozil","score":0.6460000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8920000195503235},{"id":"https://openalex.org/C2777105317","wikidata":"https://www.wikidata.org/wiki/Q4686710","display_name":"Adverse Event Reporting System","level":3,"score":0.6712999939918518},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6139000058174133},{"id":"https://openalex.org/C197636746","wikidata":"https://www.wikidata.org/wiki/Q7234359","display_name":"Postmarketing surveillance","level":3,"score":0.5246000289916992},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.5083000063896179},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.48080000281333923},{"id":"https://openalex.org/C199475168","wikidata":"https://www.wikidata.org/wiki/Q1539689","display_name":"MedDRA","level":4,"score":0.3736000061035156},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3675000071525574},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.35269999504089355},{"id":"https://openalex.org/C77350462","wikidata":"https://www.wikidata.org/wiki/Q1125472","display_name":"Confounding","level":2,"score":0.34779998660087585},{"id":"https://openalex.org/C2780176905","wikidata":"https://www.wikidata.org/wiki/Q6673122","display_name":"Thyroid disease","level":3,"score":0.34619998931884766},{"id":"https://openalex.org/C2777075537","wikidata":"https://www.wikidata.org/wiki/Q929737","display_name":"Liver disease","level":2,"score":0.32330000400543213},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3188999891281128},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.3086000084877014},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.302700012922287},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.302700012922287},{"id":"https://openalex.org/C9357733","wikidata":"https://www.wikidata.org/wiki/Q6878417","display_name":"Missing data","level":2,"score":0.3009999990463257},{"id":"https://openalex.org/C2777214474","wikidata":"https://www.wikidata.org/wiki/Q147778","display_name":"Cirrhosis","level":2,"score":0.29980000853538513},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.2930999994277954},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.2913999855518341},{"id":"https://openalex.org/C151956035","wikidata":"https://www.wikidata.org/wiki/Q1132755","display_name":"Logistic regression","level":2,"score":0.28360000252723694},{"id":"https://openalex.org/C121117317","wikidata":"https://www.wikidata.org/wiki/Q4439221","display_name":"Credible interval","level":3,"score":0.2825999855995178},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2786000072956085},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.27399998903274536},{"id":"https://openalex.org/C2779356329","wikidata":"https://www.wikidata.org/wiki/Q922625","display_name":"Checklist","level":2,"score":0.2639000117778778},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.26080000400543213},{"id":"https://openalex.org/C64869954","wikidata":"https://www.wikidata.org/wiki/Q1859747","display_name":"False positive paradox","level":2,"score":0.2533000111579895}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.3389/fphar.2026.1934274","doi":"https://doi.org/10.3389/fphar.2026.1934274","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1934274","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1934274/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:b01d8f1b31934d07a5ea389bb5cb96fe","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/b01d8f1b31934d07a5ea389bb5cb96fe","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Frontiers in Pharmacology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.3389/fphar.2026.1934274","doi":"https://doi.org/10.3389/fphar.2026.1934274","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fphar.2026.1934274","pdf_url":"https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2026.1934274/pdf","source":{"id":"https://openalex.org/S132108250","display_name":"Frontiers in Pharmacology","issn_l":"1663-9812","issn":["1663-9812"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","ki-jl-1","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9922999739646912,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7224331014.pdf","grobid_xml":"https://content.openalex.org/works/W7224331014.grobid-xml"},"referenced_works_count":57,"referenced_works":["https://openalex.org/W1988100739","https://openalex.org/W2015487160","https://openalex.org/W3049450321","https://openalex.org/W3102426258","https://openalex.org/W3133899324","https://openalex.org/W3154897461","https://openalex.org/W3183166775","https://openalex.org/W4306867885","https://openalex.org/W4309039172","https://openalex.org/W4319299284","https://openalex.org/W4386910063","https://openalex.org/W4387297067","https://openalex.org/W4387666937","https://openalex.org/W4389509458","https://openalex.org/W4391592880","https://openalex.org/W4391653666","https://openalex.org/W4391831812","https://openalex.org/W4392530100","https://openalex.org/W4393992983","https://openalex.org/W4396559574","https://openalex.org/W4398179782","https://openalex.org/W4399212640","https://openalex.org/W4399435116","https://openalex.org/W4399788794","https://openalex.org/W4400342554","https://openalex.org/W4400521208","https://openalex.org/W4400849721","https://openalex.org/W4401213940","https://openalex.org/W4401712318","https://openalex.org/W4401882456","https://openalex.org/W4402210752","https://openalex.org/W4402350754","https://openalex.org/W4403484949","https://openalex.org/W4403544061","https://openalex.org/W4403566401","https://openalex.org/W4404799612","https://openalex.org/W4404816270","https://openalex.org/W4405481252","https://openalex.org/W4408204932","https://openalex.org/W4408807168","https://openalex.org/W4409351940","https://openalex.org/W4409963211","https://openalex.org/W4410264220","https://openalex.org/W4410634587","https://openalex.org/W4411135430","https://openalex.org/W4411306823","https://openalex.org/W4411450834","https://openalex.org/W4412491348","https://openalex.org/W4412523229","https://openalex.org/W4414195829","https://openalex.org/W4415468628","https://openalex.org/W4416011441","https://openalex.org/W4416083516","https://openalex.org/W4416572720","https://openalex.org/W7138956279","https://openalex.org/W7151222588","https://openalex.org/W7165174889"],"related_works":["https://openalex.org/W7166154556","https://openalex.org/W7203780249","https://openalex.org/W4416100574","https://openalex.org/W7221097957","https://openalex.org/W4416894975","https://openalex.org/W7114776748","https://openalex.org/W7221107142","https://openalex.org/W4412573054","https://openalex.org/W6902428118","https://openalex.org/W7163682105"],"abstract_inverted_index":{"Background":[0],"Resmetirom":[1],"is":[2],"the":[3,258],"first":[4,193],"approved":[5],"liver-directed":[6],"thyroid":[7],"hormone":[8],"receptor-beta":[9],"agonist":[10],"for":[11,122,128,176,181,185,190],"noncirrhotic":[12],"metabolic":[13],"dysfunction-associated":[14],"steatohepatitis":[15],"(MASH)":[16],"with":[17,209],"fibrosis.":[18],"Early":[19,233],"liver-event":[20],"reporting":[21,135,235],"may":[22],"be":[23],"distorted":[24],"by":[25],"indication":[26],"leakage":[27],"(the":[28],"treated":[29],"disease":[30,38],"or":[31,59,272],"its":[32],"manifestations":[33],"recorded":[34],"as":[35],"adverse":[36],"events),":[37],"progression,":[39],"and":[40,67,74,85,100,125,133,148,165,187,222,228,243,266,281],"surveillance":[41],"bias.":[42],"Methods":[43],"We":[44],"analyzed":[45],"FDA":[46],"Adverse":[47],"Event":[48],"Reporting":[49],"System":[50],"(FAERS)":[51],"data":[52],"from":[53,212],"2024Q1":[54],"through":[55],"2026Q1.":[56],"Deduplicated":[57],"primary-":[58],"secondary-suspect":[60],"reports":[61,109,147,202,213],"were":[62,110,119,173,224],"assessed":[63],"at":[64],"preferred-term,":[65],"system-organ-class,":[66],"nine":[68],"predefined":[69],"clinical-cluster":[70],"levels":[71],"using":[72],"frequentist":[73],"Bayesian":[75],"disproportionality":[76],"metrics.":[77],"References":[78],"included":[79],"all":[80,113],"FAERS,":[81],"US":[82],"MASH-indication":[83],"reports,":[84,115],"an":[86],"exploratory":[87],"144-report":[88],"active":[89,160],"comparator.":[90],"Sensitivity":[91],"analyses":[92],"examined":[93],"cirrhosis":[94],"indications,":[95],"serious":[96],"outcomes,":[97],"onset-data":[98],"selection,":[99],"co-medications.":[101],"Results":[102],"Among":[103],"3,155,054":[104],"deduplicated":[105],"cases,":[106,230],"1,429":[107],"resmetirom":[108],"analyzed.":[111],"Versus":[112],"non-resmetirom":[114],"RORs":[116,172],"(95%":[117],"CIs)":[118],"12.13":[120],"(10.61\u201313.88)":[121],"hepatocellular":[123],"injury":[124],"11.46":[126],"(9.24\u201314.21)":[127],"cholestasis/biliary":[129],"events.":[130],"Gastrointestinal,":[131],"thyroid/metabolic,":[132],"rash/hypersensitivity":[134],"was":[136,217],"also":[137],"enriched.":[138],"Hepatic":[139],"estimates":[140,252],"remained":[141,198],"elevated":[142],"after":[143],"excluding":[144],"35":[145],"cirrhosis-indication":[146],"in":[149,219,226],"restricted":[150],"comparisons,":[151],"although":[152],"sparse":[153],"cells":[154],"produced":[155],"wide":[156],"confidence":[157],"intervals.":[158],"The":[159,192],"comparator":[161],"comprised":[162],"142":[163],"GLP-1/GIP":[164],"two":[166],"pioglitazone":[167],"reports.":[168],"Against":[169],"this":[170],"reference,":[171],"1.36":[174],"(0.93\u20131.99)":[175],"gastrointestinal":[177],"intolerance,":[178],"0.93":[179],"(0.59\u20131.47)":[180],"nausea,":[182],"1.42":[183],"(0.18\u201311.18)":[184],"cholelithiasis,":[186],"1.95":[188],"(1.12\u20133.41)":[189],"diarrhoea.":[191],"three":[194,227],"attenuated,":[195],"whereas":[196],"diarrhoea":[197],"elevated.":[199],"Only":[200],"206":[201],"(14.4%)":[203],"had":[204],"valid":[205],"exact":[206],"onset":[207],"dates,":[208],"systematic":[210],"differences":[211],"lacking":[214],"dates.":[215],"Sex":[216],"missing":[218,262],"94.6%.":[220],"Gemfibrozil":[221],"clopidogrel":[223],"co-reported":[225],"25":[229],"respectively.":[231],"Conclusion":[232],"FAERS":[234],"patterns":[236,277],"recapitulated":[237],"recognized":[238],"gastrointestinal,":[239],"hepatic,":[240],"biliary,":[241],"cutaneous,":[242],"thyroid/metabolic":[244],"domains.":[245],"Comparator-dependent":[246],"attenuation":[247],"suggests":[248],"that":[249],"crude":[250],"all-FAERS":[251],"partly":[253],"reflect":[254],"treatment-context":[255],"reporting.":[256],"However,":[257],"small":[259],"GLP-1/GIP-dominant":[260],"comparator,":[261],"data,":[263],"target-organ":[264],"confounding,":[265],"spontaneous-report":[267],"limitations":[268],"preclude":[269],"incidence,":[270],"comparative-risk,":[271],"causal":[273],"inference.":[274],"These":[275],"hypothesis-generating":[276],"support":[278],"clinical":[279],"monitoring":[280],"denominator-based":[282],"confirmation.":[283]},"counts_by_year":[],"updated_date":"2026-11-01T11:40:01.658920","created_date":"2026-10-30T00:00:00"}